{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:28:46Z","timestamp":1768519726006,"version":"3.49.0"},"reference-count":139,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/aog.0b013e3182a5fdfd","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T15:21:31Z","timestamp":1378567291000},"page":"885-900","source":"Crossref","is-referenced-by-count":27,"title":["Prophylaxis and Treatment of Anthrax in Pregnant Women"],"prefix":"10.1097","volume":"122","author":[{"given":"Dana","family":"Meaney-Delman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja A.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.","family":"Beigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne E.","family":"Zotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalonda","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Bower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracee A.","family":"Treadwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise J.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-23-20210728","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid0810.020349","article-title":". Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.","volume":"8","author":"Shepard","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"R2-23-20210728","first-page":"1014","article-title":"Update: interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax.","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-23-20210728","first-page":"366","article-title":"ACOG Committee on Obstetric Practice. ACOG Committee Opinion number 268, February 2002. American College of Obstetricians and Gynecologists.","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R7-23-20210728","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":". Anthrax as a biological weapon, 2002: updated recommendations for management.","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"R8-23-20210728","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-144-4-200602210-00009","article-title":"Systematic review: a century of inhalational anthrax cases from 1900 to 2005.","volume":"144","author":"Holty","year":"2006","journal-title":"Ann Intern Med"},{"key":"R9-23-20210728","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":". Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"R10-23-20210728","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/AOG.0b013e318270ec08","article-title":". Anthrax cases in pregnant and postpartum women: a systematic review.","volume":"120","author":"Meaney-Delman","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R11-23-20210728","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.","volume":"59","author":"Wright","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R12-23-20210728","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/019262339202000313","article-title":"Quinolone arthropathyacute toxicity to immature articular cartilage.","volume":"20","author":"Gough","year":"1992","journal-title":"Toxicol Pathol"},{"key":"R15-23-20210728","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archpedi.1963.02080040455005","article-title":"Growth inhibition of prematures receiving tetracycline.","volume":"105","author":"Cohlan","year":"1963","journal-title":"Am J Dis Child"},{"key":"R16-23-20210728","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0002-9378(66)90328-0","article-title":"Discoloration of deciduous teeth induced by administration of tetracycline antepartum.","volume":"96","author":"Kutscher","year":"1966","journal-title":"Am J Obstet Gynecol"},{"key":"R20-23-20210728","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/000992288202100910","article-title":"Gray baby syndrome revisited.","volume":"21","author":"Krasinski","year":"1982","journal-title":"Clin Pediatr (Phila)"},{"key":"R21-23-20210728","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.clpt.6100126","article-title":". Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies.","volume":"81","author":"Andrew","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R22-23-20210728","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/infdis\/136.3.370","article-title":"Pharmacokinetics of ampicillin during pregnancy.","volume":"136","author":"Philipson","year":"1977","journal-title":"J Infect Dis"},{"key":"R23-23-20210728","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-9378(78)90327-7","article-title":"Plasma levels of ampicillin in pregnant women following administration of ampicillin and pivampicillin.","volume":"130","author":"Philipson","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"R24-23-20210728","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.clpt.6100136","article-title":"Obstetric clinical pharmacology: coming of age.","volume":"81","author":"Zajicek","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R25-23-20210728","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/01.AOG.0000216197.26783.b5","article-title":"Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks.","volume":"107","author":"Nahum","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R26-23-20210728","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejogrb.2008.12.007","article-title":"The safety of quinolones-a meta-analysis of pregnancy outcomes.","volume":"143","author":"Bar-Oz","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R28-23-20210728","first-page":"535","article-title":"Safety of the new quinolones in pregnancy.","volume":"84","author":"Berkovitch","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R29-23-20210728","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003495-199300453-00206","article-title":"Ciprofloxacin use during pregnancy.","volume":"45","author":"Bomford","year":"1993","journal-title":"Drugs"},{"key":"R30-23-20210728","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-3016.2008.00978.x","article-title":". Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.","volume":"23","author":"Cooper","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R31-23-20210728","first-page":"919","article-title":"Teratogenicity of antibacterial agents.","volume":"32","author":"Eric","year":"2008","journal-title":"Coll Antropol"},{"key":"R32-23-20210728","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(95)92191-5","article-title":"Ciprofloxacin for multiresistant enteric fever in pregnancy.","volume":"346","author":"Koul","year":"1995","journal-title":"Lancet"},{"key":"R33-23-20210728","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/AAC.42.6.1336","article-title":". Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study.","volume":"42","author":"Loebstein","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R34-23-20210728","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0301-2115(95)02524-3","article-title":". Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS).","volume":"69","author":"Schaefer","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R35-23-20210728","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1471-0528.1998.tb10234.x","article-title":"The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England.","volume":"105","author":"Wilton","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R36-23-20210728","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijantimicag.2005.06.017","article-title":"Further analysis of the risk of adverse birth outcome after maternal use of fluoroquinolones.","volume":"26","author":"Wogelius","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"R37-23-20210728","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(87)80543-7","article-title":"Predictive value of minor anomalies. I. Association with major malformations.","volume":"110","author":"Leppig","year":"1987","journal-title":"J Pediatr"},{"key":"R38-23-20210728","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0924-8579(01)00390-9","article-title":"Birth outcome following maternal use of fluoroquinolones.","volume":"18","author":"Larsen","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"R39-23-20210728","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1016\/0002-9343(89)90021-1","article-title":"Pharmacokinetics of three newer quinolones in pregnant and lactating women.","volume":"87","author":"Giamarellou","year":"1989","journal-title":"Am J Med"},{"key":"R40-23-20210728","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2004.11.031","article-title":". Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.","volume":"122","author":"Polachek","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R41-23-20210728","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1447-0756.2010.01246.x","article-title":"Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime.","volume":"36","author":"Ozyuncu","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"R42-23-20210728","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijantimicag.2010.03.011","article-title":"Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone.","volume":"36","author":"Ozyuncu","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"R43-23-20210728","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/138620710791516003","article-title":". Comparison of pharmacokinetic profiles of moxifloxacin in Caesarean versus non-pregnant sectioned women by fully validated HPLC with fluorescence detection.","volume":"13","author":"Nemutlu","year":"2010","journal-title":"Comb Chem High Throughput Screen"},{"key":"R44-23-20210728","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0029-7844(97)00005-7","article-title":"Teratogenic study of doxycycline.","volume":"89","author":"Czeizel","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R45-23-20210728","first-page":"315","article-title":"The role of mycoplasma among 81 consecutive pregnancies: a prospective study.","volume":"25","author":"Horne","year":"1980","journal-title":"Int J Fertil"},{"key":"R46-23-20210728","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.reprotox.2007.07.011","article-title":"Effect of doxycycline treatment during pregnancy for birth outcomes.","volume":"24","author":"Kazy","year":"2007","journal-title":"Reprod Toxicol"},{"key":"R47-23-20210728","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.2179","article-title":"Maternal use of antibiotics and the risk of orofacial clefts: a nationwide cohort study.","volume":"21","author":"Molgaard-Nielsen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R48-23-20210728","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","article-title":"Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study.","volume":"163","author":"Crider","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R49-23-20210728","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.contraception.2008.09.006","article-title":"Doxycycline serum levels at the time of dilation and evacuation with two dosing regimens.","volume":"79","author":"Reeves","year":"2009","journal-title":"Contraception"},{"key":"R50-23-20210728","first-page":"202","article-title":"Effect on birth weight of erythromycin treatment of pregnant women.","volume":"69","author":"McCormack","year":"1987","journal-title":"Obstet Gynecol"},{"key":"R51-23-20210728","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cpt197619168","article-title":"Erythromycin and clindamycin absorption and elimination in pregnant women.","volume":"19","author":"Phillipson","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"R52-23-20210728","first-page":"190","article-title":"Pharmacokinetic studies of clindamycin phosphate.","volume":"13","author":"DeHaan","year":"1973","journal-title":"J Clin Pharmacol"},{"key":"R53-23-20210728","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/AAC.01017-09","article-title":". Pharmacokinetics of clindamycin in pregnant women in the peripartum period.","volume":"54","author":"Muller","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R54-23-20210728","first-page":"124","article-title":"3rd, Bawdon RE, Burris J. Antibiotic concentration in maternal blood, cord blood, and placental membranes in chorioamnionitis.","volume":"72","author":"Gilstrap","year":"1988","journal-title":"Obstet Gynecol"},{"key":"R55-23-20210728","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM197306072882307","article-title":"Transplacental passage of erythromycin and clindamycin.","volume":"288","author":"Philipson","year":"1973","journal-title":"N Engl J Med"},{"key":"R56-23-20210728","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9378(16)33336-1","article-title":"Placental transfer of clindamycin and gentamicin in term pregnancy.","volume":"124","author":"Weinstein","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"R57-23-20210728","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2125.2004.02138.x","article-title":". First-trimester exposure to amoxycillinclavulanic acid: a prospective, controlled study.","volume":"58","author":"Berkovitch","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"R58-23-20210728","first-page":"33","article-title":"Treatment of gonorrhea in pregnancy.","volume":"81","author":"Cavenee","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R59-23-20210728","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0301-2115(00)00545-5","article-title":"Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study.","volume":"97","author":"Czeizel","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R60-23-20210728","first-page":"103","article-title":"Beta-lactam antibiotics during pregnancy: a cross-sectional comparative study Zagreb-Novi Sad.","volume":"16","author":"Eric","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R61-23-20210728","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1365-2125.2003.01750.x","article-title":"A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark.","volume":"55","author":"Jepsen","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"R62-23-20210728","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/EDE.0b013e318258cb05","article-title":"Maternal exposure to amoxicillin and the risk of oral clefts.","volume":"23","author":"Lin","year":"2012","journal-title":"Epidemiology"},{"key":"R63-23-20210728","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1034\/j.1600-0412.2001.080008753.x","article-title":"Antibiotic treatment for threatened abortion during the early first trimester in women with previous spontaneous abortion.","volume":"80","author":"Ou","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R64-23-20210728","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1128\/AAC.27.4.508","article-title":"Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy.","volume":"27","author":"Pedler","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"R65-23-20210728","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1597\/05-208.1","article-title":"Drug treatment during pregnancy and isolated orofacial clefts in Hungary.","volume":"44","author":"Puho","year":"2007","journal-title":"Cleft Palate Craniofac J"},{"key":"R66-23-20210728","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.olq.0000187226.32145.ea","article-title":". An observational cohort study of Chlamydia trachomatis treatment in pregnancy.","volume":"33","author":"Rahangdale","year":"2006","journal-title":"Sex Transm Dis"},{"key":"R67-23-20210728","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-9926(199801)57:1<1::AID-TERA1>3.0.CO;2-6","article-title":"Maternal illness, including fever and medication use as risk factors for neural tube defects.","volume":"57","author":"Shaw","year":"1998","journal-title":"Teratology"},{"key":"R68-23-20210728","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1185\/03007997509114794","article-title":"Gastro-intestinal absorption and transplacental transfer of amoxycillin during labour and the influence of metoclopramide.","volume":"3","author":"Buckingham","year":"1975","journal-title":"Curr Med Res Opin"},{"key":"R70-23-20210728","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/AAC.00119-08","article-title":". Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera.","volume":"53","author":"Muller","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R71-23-20210728","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1023\/A:1007623408010","article-title":"A population-based case-control teratologic study of oral chloramphenicol treatment during pregnancy.","volume":"16","author":"Czeizel","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"R72-23-20210728","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJM198505093121905","article-title":"Penicillin allergy and desensitization in serious infections during pregnancy.","volume":"312","author":"Wendel","year":"1985","journal-title":"N Engl J Med"},{"key":"R73-23-20210728","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jama.1981.03320040015021","article-title":"First-trimester drug use and congenital disorders.","volume":"246","author":"Jick","year":"1981","journal-title":"JAMA"},{"key":"R74-23-20210728","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/00016347609156779","article-title":"A prospective study of drugs and pregnancy. I. Psychopharmaca.","volume":"55","author":"Kullander","year":"1976","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R75-23-20210728","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ije\/4.1.37","article-title":"Associations between oral clefts and drugs taken during pregnancy.","volume":"4","author":"Saxen","year":"1975","journal-title":"Int J Epidemiol"},{"key":"R76-23-20210728","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s004040050277","article-title":"Oral phenoxymethylpenicillin treatment during pregnancy. Results of a population-based Hungarian case-control study.","volume":"263","author":"Czeizel","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"R77-23-20210728","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1067\/mob.2001.117353","article-title":"Optimal dosing of penicillin G in the third trimester of pregnancy for prophylaxis against group B Streptococcus.","volume":"185","author":"Johnson","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R78-23-20210728","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/inf.1970.2.issue-2.09","article-title":"Transplacental passage of azidocillin, ampicillin and penicillin G during early and late pregnancy.","volume":"2","author":"Wasz-Hockert","year":"1970","journal-title":"Scand J Infect Dis"},{"key":"R79-23-20210728","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.1946.02870290019007","article-title":"The transmission of penicillin to the previable fetus; its significance in prenatal syphilis.","volume":"131","author":"Woltz","year":"1946","journal-title":"J Am Med Assoc"},{"key":"R80-23-20210728","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0029-7844(97)00247-0","article-title":"Persistence of penicillin G benzathine in pregnant group B streptococcus carriers.","volume":"90","author":"Weeks","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R81-23-20210728","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-9378(15)30214-3","article-title":"The transmission of penicillin through the placenta. A preliminary report.","volume":"49","author":"Hutter","year":"1945","journal-title":"J Obstet Gynecol"},{"key":"R82-23-20210728","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1177\/1352458511401944","article-title":"Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment.","volume":"17","author":"Hellwig","year":"2011","journal-title":"Mult Scler"},{"key":"R83-23-20210728","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0002-9378(16)40087-6","article-title":"The transmission of penicillin to amniotic fluid and fetal blood in the human.","volume":"50","author":"Woltz","year":"1945","journal-title":"Am J Obstet Gynecol"},{"key":"R84-23-20210728","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1067\/mob.2001.113907","article-title":"A population-based case-control teratologic study of ampicillin treatment during pregnancy.","volume":"185","author":"Czeizel","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R85-23-20210728","first-page":"451","article-title":"First-trimester drug use and congenital disorders.","volume":"65","author":"Aselton","year":"1985","journal-title":"Obstet Gynecol"},{"key":"R86-23-20210728","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(88)70195-4","article-title":"Use of oral and topical agents for acne in pregnancy.","volume":"19","author":"Rothman","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"R87-23-20210728","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/bdra.20431","article-title":"Use of specified critical periods of different congenital abnormalities instead of the first trimester concept.","volume":"82","author":"Czeizel","year":"2008","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R88-23-20210728","first-page":"11","article-title":"Amoxycillin and ampicillin: a study of their use in pregnancy.","volume":"107-","author":"Colley","year":"1983","journal-title":"Aust J Pharm"},{"key":"R89-23-20210728","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM198508083130603","article-title":"Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy.","volume":"313","author":"Zierler","year":"1985","journal-title":"N Engl J Med"},{"key":"R90-23-20210728","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0002-9378(93)90515-K","article-title":"Pharmacokinetics of ampicillin and sulbactam in pregnancy.","volume":"168","author":"Chamberlain","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R91-23-20210728","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007691-198303000-00003","article-title":"Intravenous ampicillin pharmacokinetics in the third trimester of pregnancy.","volume":"5","author":"Kubacka","year":"1983","journal-title":"Ther Drug Monit"},{"key":"R92-23-20210728","first-page":"121","article-title":"Persistance of ampicillin in the intrauterine content following single and multiple doses to pregnant women.","volume":"60","author":"Philipson","year":"1981","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R93-23-20210728","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/00016348009154086","article-title":"Study of ampicillin levels in maternal serum, umbilical cord serum and amniotic fluid following administration of pivampicillin.","volume":"59","author":"Jordheim","year":"1980","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R94-23-20210728","first-page":"974","article-title":"Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved Am J Obstet G","volume":"175","author":"Bloom","year":"1996","journal-title":"ynecol"},{"key":"R95-23-20210728","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-2007-1000028","article-title":"The placental transfer of ampicillin.","volume":"1","author":"Adamkin","year":"1984","journal-title":"Am J Perinatol"},{"key":"R96-23-20210728","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/jpme.1980.8.1.13","article-title":"Ampicillin and gemtamicin in the treatment of fetal intrauterine infections.","volume":"8","author":"Creatsas","year":"1980","journal-title":"J Perinat Med"},{"key":"R97-23-20210728","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0002-9378(16)32738-7","article-title":"Transplacental ampicillin: inhibitory concentrations in neonatal serum.","volume":"138","author":"Kraybill","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"R98-23-20210728","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.1979.03290380021019","article-title":"Ampicillin prevents intrapartum transmission of group B streptococcus.","volume":"241","author":"Yow","year":"1979","journal-title":"JAMA"},{"key":"R99-23-20210728","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0002-9378(66)90438-8","article-title":"Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancy.","volume":"96","author":"Bray","year":"1966","journal-title":"Am J Obstet Gynecol"},{"key":"R100-23-20210728","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0002-9378(66)90439-X","article-title":"Placental transfer of ampicillin.","volume":"96","author":"MacAulay","year":"1966","journal-title":"Am J Obstet Gynecol"},{"key":"R101-23-20210728","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2005.07.098","article-title":"Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of Group B Streptococcus.","volume":"194","author":"Colombo","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R102-23-20210728","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01641464","article-title":"Transfer of ampicillin to the fetus and amniotic fluid during continuous infusion (steady state) and by repeated single intravenous injections to the mother.","volume":"2","author":"Hirsch","year":"1974","journal-title":"Infection"},{"key":"R103-23-20210728","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1471-0528.1973.tb02149.x","article-title":"Distribution of parenteral ampicillin and cephalosporins in late pregnancy.","volume":"80","author":"Stewart","year":"1973","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"R104-23-20210728","first-page":"321","article-title":"Data on the tissue concentration of antibiotics in man tissue concentrations of semi-synthetic penicillins in the fetus.","volume":"4","author":"Biro","year":"1970","journal-title":"Int Z Klin Pharmakol Ther Toxikol"},{"key":"R105-23-20210728","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1471-0528.1967.tb15570.x","article-title":"The prophylactic use of ampicillin and its trans-placental passage after amniotomy.","volume":"74","author":"Fisher","year":"1967","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"R106-23-20210728","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000294878","article-title":"3rd. Antibiotic concentration in maternal blood, cord blood and placental tissue in women with chorioamnionitis.","volume":"33","author":"Maberry","year":"1992","journal-title":"Gynecol Obstet Invest"},{"key":"R107-23-20210728","first-page":"223","article-title":"Passage of penicillins from mother to foetus in humans.","volume":"6","author":"Elek","year":"1972","journal-title":"Int J Clin Pharmacol"},{"key":"R108-23-20210728","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bmj.1.5480.137","article-title":"Transplacental passage of ampicillin.","volume":"1","author":"Blecher","year":"1966","journal-title":"Br Med J"},{"key":"R109-23-20210728","first-page":"72","article-title":"Ampicillin: transfer into fetus and amniotic fluid.","volume":"65","author":"Bolognese","year":"1968","journal-title":"Rocky Mt Med J"},{"key":"R110-23-20210728","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/S0264-410X(03)00353-0","article-title":"Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine.","volume":"21","author":"Baker","year":"2003","journal-title":"Vaccine"},{"key":"R111-23-20210728","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1155\/2005\/961356","article-title":"Transfer of meropenem in the ex vivo human placenta perfusion model.","volume":"13","author":"Hnat","year":"2005","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R112-23-20210728","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.trstmh.2011.06.003","article-title":"Outcomes of 19 pregnant women with brucellosis in Babol, northern Iran.","volume":"105","author":"Roushan","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R113-23-20210728","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1258\/td.2011.100386","article-title":"Brucellosis in pregnancy.","volume":"41","author":"Gulsun","year":"2011","journal-title":"Trop Doct"},{"key":"R114-23-20210728","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/319758","article-title":"Brucellosis in pregnant women.","volume":"32","author":"Khan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R115-23-20210728","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0163-4453(92)92928-C","article-title":"Reactivation of tuberculous lymphadenitis during pregnancy.","volume":"24","author":"Warner","year":"1992","journal-title":"J Infect"},{"key":"R116-23-20210728","first-page":"87","article-title":". Haemorrhagic disease of the newborn in the offspring of rifampicin and isoniazid treated mothers.","volume":"29","author":"Eggermont","year":"1976","journal-title":"Acta Paediatr Belg"},{"key":"R117-23-20210728","first-page":"706","article-title":"Pregnancy and pulmonary tuberculosis.","volume":"46","author":"Schaefer","year":"1975","journal-title":"Obstet Gynecol"},{"key":"R118-23-20210728","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0002-9378(73)90401-8","article-title":"Tuberculosis complicated by pregnancy.","volume":"115","author":"Wilson","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"R119-23-20210728","first-page":"457","article-title":"Antileprosy drugs, pregnancy and fetal outcome.","volume":"64","author":"Bhargava","year":"1996","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"R120-23-20210728","first-page":"65","article-title":"Treatment of tuberculosis during pregnancy.","volume":"122","author":"Snider","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"R121-23-20210728","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0140-6736(77)91447-7","article-title":"Rifampicin in pregnancy.","volume":"2","author":"Steen","year":"1977","journal-title":"Lancet"},{"key":"R122-23-20210728","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(77)90056-3","article-title":"Rifampicin in early pregnancy.","volume":"2","author":"Rocker","year":"1977","journal-title":"Lancet"},{"key":"R123-23-20210728","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/978-1-4684-3219-0_43","article-title":"On the possible teratogenicity of antibiotic drugs administered during pregnancya prospective study.","volume":"27","author":"Ravid","year":"1972","journal-title":"Adv Exp Med Biol"},{"key":"R124-23-20210728","first-page":"136","article-title":"Treatment of typhoid fever in pregnancy.","volume":"3","author":"Buongiorno","year":"1984","journal-title":"Chemioterapia"},{"key":"R125-23-20210728","first-page":"112","article-title":"Acute pyelonephritis of pregnancy: a clinical review.","volume":"42","author":"Cunningham","year":"1973","journal-title":"Obstet Gynecol"},{"key":"R126-23-20210728","first-page":"27","article-title":"Treatment of pyelonephritis in pregnancy.","volume":"34","author":"Hibbard","year":"1966","journal-title":"Trans Pac Coast Obstet Gynecol Soc"},{"key":"R127-23-20210728","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1001\/jama.1950.72910350005010a","article-title":"Placental transmission of chloramphenicol (chloromycetin).","volume":"142","author":"Ross","year":"1950","journal-title":"J Am Med Assoc"},{"key":"R128-23-20210728","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.1950.02910350001001","article-title":"Placental transfer of chloramphenicol (chloromycetin).","volume":"142","author":"Scott","year":"1950","journal-title":"J Am Med Assoc"},{"key":"R129-23-20210728","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/01.AOG.0000260388.78339.b6","article-title":"Transplacental passage of vancomycin in noninfected term pregnant women.","volume":"109","author":"Laiprasert","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R130-23-20210728","first-page":"977","article-title":"Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant Am J Obstet G","volume":"161","author":"Reyes","year":"1989","journal-title":"ynecol"},{"key":"R131-23-20210728","first-page":"93","article-title":"Vancomycin in pregnancy.","volume":"93","author":"MacCulloch","year":"1981","journal-title":"N Z Med J"},{"key":"R132-23-20210728","first-page":"709","article-title":"Single-dose antibiotic prophylaxis in high-risk patients undergoing cesarean section. A comparative trial.","volume":"31","author":"Saltzman","year":"1986","journal-title":"J Reprod Med"},{"key":"R133-23-20210728","first-page":"908","article-title":"Transplacental passage of vancomycin during the second trimester of pregnancy.","volume":"78","author":"Bourget","year":"1991","journal-title":"Obstet Gynecol"},{"key":"R134-23-20210728","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/clinids\/17.1.139","article-title":"Successful antepartum treatment of listeriosis with vancomycin plus netilmicin.","volume":"17","author":"Bonacorsi","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R135-23-20210728","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/0002-9343(89)90018-1","article-title":"Ciprofloxacin: toxicologic evaluation of additional safety data.","volume":"87","author":"Schluter","year":"1989","journal-title":"Am J Med"},{"key":"R136-23-20210728","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF01728929","article-title":"Safety and efficacy of ciprofloxacin in paediatric patientsreview.","volume":"21","author":"Kubin","year":"1993","journal-title":"Infection"},{"key":"R137-23-20210728","first-page":"135","article-title":"Tetracycline-associated fatty liver of pregnancy, including possible pregnancy risk after chronic dermatologic use of tetracycline.","volume":"26","author":"Wenk","year":"1981","journal-title":"J Reprod Med"},{"key":"R138-23-20210728","first-page":"31","article-title":"The use of progestational agents in pregnancy.","volume":"62","author":"Allen","year":"1965","journal-title":"Rocky Mt Med J"},{"key":"R139-23-20210728","first-page":"75","article-title":"Effect of administration of tetracycline in pregnancy on the primary dentition of the offspring.","volume":"25","author":"Genot","year":"1970","journal-title":"J Oral Med"},{"key":"R140-23-20210728","first-page":"668","article-title":"Controlled study of the effect of prenatal tetracycline on primary dentition.","volume":"5","author":"Porter","year":"1965","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"key":"R141-23-20210728","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00381-011-1441-x","article-title":"Diagnostic and management of pediatric brain stem abscess, a case-based update.","volume":"27","author":"Ghannane","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"R142-23-20210728","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-3016.2009.01025.x","article-title":"Risk factors for oral clefts: a population-based case-control study in Shenyang, China.","volume":"23","author":"Wang","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R143-23-20210728","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/bdra.20369","article-title":"High fever-related maternal diseases as possible causes of multiple congenital abnormalities: a population-based case-control study.","volume":"79","author":"Czeizel","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R144-23-20210728","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001648-200109000-00004","article-title":"Congenital heart defects, maternal febrile illness, and multivitamin use: a population-based study.","volume":"12","author":"Botto","year":"2001","journal-title":"Epidemiology"},{"key":"R145-23-20210728","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/bdra.20735","article-title":". Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006.","volume":"88","author":"Parker","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R147-23-20210728","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/ajmg.a.32854","article-title":". Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004.","volume":"149A","author":"Genisca","year":"2009","journal-title":"Am J Med Genet A"},{"key":"R148-23-20210728","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s10995-011-0902-x","article-title":". Medication Exposure in Pregnancy Risk Evaluation Program.","volume":"16","author":"Andrade","year":"2012","journal-title":"Matern Child Health J"},{"key":"R149-23-20210728","first-page":"239","article-title":"FDA pregnancy risk categories and the CPS: do they help or are they a hindrance Can Fam P","volume":"56","author":"Law","year":"2010","journal-title":"hysician"},{"key":"R150-23-20210728","first-page":"333","article-title":"Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks Am J Obstet G","volume":"187","author":"Doering","year":"2002","journal-title":"ynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201310000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T01:02:30Z","timestamp":1627434150000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201310000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":139,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3182a5fdfd","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}